#
Lansoprazole Orally Disintegrating Tablets
  • Professionals
  • FDA PI

Lansoprazole Orally Disintegrating Tablets

Dosage form: tablet, orally disintegrating, delayed release
Drug class:Proton pump inhibitors

Medically reviewed by Drugs.com. Last updated on Dec 1, 2021.

Indications and Usage for Lansoprazole Orally Disintegrating Tablets

Treatment of Active Duodenal Ulcer

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (for four weeks) for healing and symptom relief of active duodenal ulcer [see Clinical Studies (14.1)].

Eradication of H. pylori to Reduce the Risk of Duodenal Ulcer Recurrence

Triple Therapy: Lansoprazole delayed-release orally disintegrating tablets/amoxicillin/clarithromycin

Lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults f...